Bios Partners
General contacts
Investor type
PE / VC
Founded
2020
AUM
$272 M
Location
Redwood City, California, United States
Investor profile last updated: 09 February, 2026
Profile
BIOS Strategic Partners specializes in distributing innovative medical technologies designed to improve patient outcomes and enhance healthcare practices. We partner with clinics, hospitals, and healthcare providers to deliver cutting-edge devices which includes AI software technology to Post Op Recovery. Our Programs and Products help accelerate recovery, enhance patient care and build Practice Management Programs. We are specialists in Workers Compensation, VA hospitals/clinics and Private sector health systems.
Our goal is to bridge the gap between groundbreaking medical innovations and the healthcare systems that need them most.
Industry
Bios Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Bios Fund II NT, LP
|
Private Equity (PE)
Venture Capital (VC)
|
Biotechnology
Healthcare Services
Medical Devices
Pharmaceuticals
HealthTech
|
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$5 M
|
October 2018
|
Contacts
Name
Title
Email
Social Networks
Investment-team contacts for Bios Partners — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
FAQs about Bios Partners
Is Bios Partners a venture capital or private equity firm?
Bios Partners is a venture capital and private equity firm. It backs companies at Seed, Series A, Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Where is Bios Partners located?
Bios Partners is located in Redwood City, California, United States.
When was Bios Partners founded?
Bios Partners was founded in 2020.
What sectors and industries does Bios Partners invest in?
Bios Partners invests in companies and startups in Biotechnology, Healthcare Services, Medical Devices, MedTech, Life Sciences, Infrastructure, HealthTech, Pharmaceuticals.
What is Bios Partners geographical focus of investments?
Bios Partners invests in companies and startups in North America.
At what stages of companies and startups does Bios Partners typically invest in?
Bios Partners invests in companies and startups at Seed, Series A, Series B, Late Stage (Series C+).
What is the usual amount of Bios Partners investment?
Bios Partners usually invests $10-50 m on average.
What is the amount of assets of under management (AUM) for Bios Partners?
Bios Partners has around $272m assets under management.
When was Bios Partners last fund created?
Bios Partners last fund was created/launched in 2018-10-01
What are the contacts of Bios Partners?
Bios Partners can be reached through its website biospartners.com and its LinkedIn page. Its general enquiries address is ir@biospartners.com. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Bios Partners — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Can I access Bios Partners data via API or MCP?
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Bios Partners directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
When was the Bios Partners profile last updated?
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 09 February, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.